Skip to content
★ Sign in to follow
IP

Initiator Pharma A/S Stock: price and insider trades · Sweden

SE·Mcap SEK 157.4MHealth Care

No insider purchase over the last 90 days. The latest, by Gunnar Magnus Severus Modée Persson, was filed 16 Apr 2018.

Initiator Pharma A/S: what insiders have been doing

Insider filings for Initiator Pharma A/S are scarce in the Finansinspektionen feed, the latest one published on 16 April 2018. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.

Insider Decl.
1
Thresholds
n/a
Buy Volume
€5,037
1 ops. · all time
Sell Volume
n/a
n/a

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Financial data

as of FY 2025

FY ended December 2025 · cache

SEK 2.30
Analyst consensus
2 analysts
·
SEK 5.17Target SEK 5.59(+143%)SEK 6.02
Income statement
Gross profit-SEK 14.8M
EBITDA-SEK 16.7M
Net income-SEK 13.7M0.0% margin
Valuation
PER (forward)-7.0x
P/Book18.5x
Beta0.14
Balance sheet & cash
Market capSEK 157.4M
Total debtSEK 2.1M
Free Cash Flow-SEK 17.7M
Debt / Equity114%
Profitability & ownership
ROE-336.2%
ROA-116.2%
% institutions0.0%
Last declaration on 16 April 2018
Declarations1 total
  • ▲
    Styrelseledamot/suppleantExecutives
    52,499 SEK15FI-SE
    6,818 shares@ SEK 7.70100.0% of flowFI:csv-599ecd4556660d250a89
    Canonical exit: 15 Jul 2018 (T+90)

1 of 1 declaration

About Initiator Pharma A/S

Initiator Pharma A/S is a Danish biopharmaceutical company focused on developing treatments for sexual disorders. It is listed on the Stockholm Stock Exchange.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations